ライフサイエンスコーパス: thyroid dysfunction

1 nganese detoxification and manganese-induced thyroid dysfunction.

2 atment of screen-detected, undiagnosed overt thyroid dysfunction.

3 with systemic reactions, renal disease, and thyroid dysfunction.

4 relationships between BDE-209 exposures and thyroid dysfunction.

5 compared to children born to mothers with no thyroid dysfunction.

6 ical entities that encompass mild degrees of thyroid dysfunction.

7 vide a candidate target for the treatment of thyroid dysfunction.

8 ce, and rhythm disturbances that result from thyroid dysfunction.

9 s determined the proportion of patients with thyroid dysfunction.

10 d to have laboratory evidence of subclinical thyroid dysfunction.

11 r than 60 years, and others at high risk for thyroid dysfunction.

12 ease and have few or no signs or symptoms of thyroid dysfunction.

13 Vigilance is required to detect and treat thyroid dysfunction.

14 patient's thyroid cells as the cause of the thyroid dysfunction.

15 Of interest, thyroid dysfunction (10 cases of hypothyroidism and 1 of

16 95 patients met the criteria for subclinical thyroid dysfunction (127 were hyperthyroid, and 168 were

17 years; range, 18 to 60 years), 36% developed thyroid dysfunction: 19 became hyperthyroid and 14 hypot

18 Thyroid dysfunction after exposure to low or moderate do

19 Data on the association between subclinical thyroid dysfunction and fractures conflict.

20 exist on the association between subclinical thyroid dysfunction and heart failure events.

21 ine Society in late 2007, and a symposium on thyroid dysfunction and pregnancy was hosted by the Amer

22 f necessary, to avoid increasing the risk of thyroid dysfunction and related adverse health effects i

23 should be aimed at detection of subclinical thyroid dysfunction and whether persons with mildly abno

24 ncluding type 2 diabetes mellitus [T2DM] and thyroid dysfunction), and osteoporosis.

25 st media include hypersensitivity reactions, thyroid dysfunction, and contrast-induced nephropathy.

26 rction, obesity, smoking, diabetes mellitus, thyroid dysfunction, and endurance exercise training all

27 thyroiditis, iodine-induced and drug-induced thyroid dysfunction, and factitious ingestion of excess

28 terial hypertension, osteoarthritis, asthma, thyroid dysfunction, and large organ fibrosis.

29 of cancer and its treatment such as anemia, thyroid dysfunction, and the neurotoxicity of cancer che

30 Inexpensive blood tests for diabetes, thyroid dysfunction, and vitamin B12 deficiency allowed

31 Although clinical signs of thyroid dysfunction are usually absent in affected males

32 s that secrete thyrotropin, and drug-induced thyroid dysfunction, are also important causes.

33 lines seemed to successfully compensate for thyroid dysfunction, as serum thyroxine/triiodothyronine

34 nvestigating exacerbating conditions such as thyroid dysfunction, but without specifying the impact o

35 Thyroid dysfunction can adversely affect somatic growth

36 Thyroid dysfunction commonly occurs with amiodarone ther

37 Thyroid dysfunction continued for 28 years after transpl

38 , including weight gain, insulin resistance, thyroid dysfunction, endothelial dysfunction, and oxidat

39 e (TSH) has increased identification of mild thyroid dysfunction, especially in elderly patients.

40 Although thyroid dysfunction has been linked to heart failure, it

41 Finally, data clarifies the effects of thyroid dysfunction, hyperparathyroidism, acromegaly and

42 amine the frequency of amiodarone-associated thyroid dysfunction in adults with congenital heart dise

43 Our goal was to assess the prevalence of thyroid dysfunction in association with 131I exposure du

44 lance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.

45 ts the importance of determining the role of thyroid dysfunction in the onset and progression of mang

46 Thyroid dysfunction is a global health concern, causing

47 Thyroid dysfunction is a known complication after hemato

48 Subclinical thyroid dysfunction is a risk factor for developing symp

49 Thyroid dysfunction is associated with poor prognosis in

50 Amiodarone-associated thyroid dysfunction is common in adults with congenital

51 Even though treatment for subclinical thyroid dysfunction is controversial, office-based scree

52 ients found by screening to have subclinical thyroid dysfunction is inconclusive.

53 of the efficacy of treatment for subclinical thyroid dysfunction is inconclusive.

54 Thyroid dysfunction is more common in adult patients wit

55 Thyroid dysfunction is suggested as a potential determin

56 sial, office-based screening to detect overt thyroid dysfunction may be indicated in women older than

57 P2 =.0049; vitiligo, P2 < 10(-6)), although thyroid dysfunction may have been related more to the le

58 , and amiodarone >200 mg/d a risk factor for thyroid dysfunction (odds ratio, 4.0; P=0.60).

59 were significant risk factors for developing thyroid dysfunction (odds ratios, 3.0 and 7.00; P=0.04 a

60 fect of treating screen-detected subclinical thyroid dysfunction on health outcomes.

61 ases such as diabetes nephrotic syndrome and thyroid dysfunction on the metabolism of apoB-containing

62 -infectious pneumonitis, had no uncontrolled thyroid dysfunction or diabetes, had no active brain met

63 Thyroid dysfunction rates are increased in patients with

64 nadequate to determine whether screening for thyroid dysfunction reduced cardiovascular disease or re

65 s indicate a direct role of IFN-gamma in the thyroid dysfunction that occurs in autoimmune thyroiditi

66 conditions represent the earliest stages of thyroid dysfunction, the benefits of detecting and treat

67 The prevalence of overt and subclinical thyroid dysfunction, the evidence for the efficacy of tr

68 us children born to mothers with no recorded thyroid dysfunction using Poisson regression models.

69 apsulated hESC-derived progenitor cells, and thyroid dysfunction was maintained for the duration of t

70 Multivariate analysis showed that thyroid dysfunction was more likely if patients were les

71 medication were controlled for, subclinical thyroid dysfunction was not associated with depression,

72 he local production of IFN-gamma can lead to thyroid dysfunction, we have generated transgenic mice t

73 progression, and consequences of subclinical thyroid dysfunction were also reviewed.

74 rms of screening for subclinical and "overt" thyroid dysfunction without clinically obvious symptoms,